Home 2024-06-13T17:56:35+01:00

Mitocin 20mg is indicated for intravesical administration for relapse prevention in superficial urinary bladder carcinoma after transurethral resection1.

It can also be used Intravenously as monochemotherapy or in combined cytostatic chemotherapy in
advanced metastatic gastric carcinoma
advanced and/or metastatic breast cancer1

Available as 20mg mitomycin vial

View the SmPC

Mitocin 20 mg, powder for solution for injection/infusion or intravesical use.

Medicine Information Request

Please complete the medicine information form about this product by following the link below.

View the SMPC
Information Request Form

Reference: 1) Mitocin SmPC